[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease 5%, driven by lower...
Source: Roche Investor Update - July 27, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Basel, 27 July 2023Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease ...
Source: Roche Media News - July 27, 2023 Category: Pharmaceuticals Source Type: news

FDA approval of immunotherapy treatment for RSV hailed by Upstate doctor as a great day for babies
Dr. Joseph Domachowske ’s research on the project dates back nearly a decade when he enrolled the first infants in the clinical trial to test the antibody. (Source: SUNY Upstate Medical)
Source: SUNY Upstate Medical - July 24, 2023 Category: Universities & Medical Training Tags: News Research Source Type: news

Potent anti-cancer therapy created using & #039;click chemistry & #039;
A potent anti-cancer therapy has been created using Nobel prize-winning "click chemistry", where molecules click together like LEGO bricks, in a new study by UCL and Stanford University researchers. The study, published in Nature Chemistry, opens up new possibilities for how cutting-edge cancer immunotherapies might be built in future. (Source: World Pharma News)
Source: World Pharma News - July 24, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

SII manufactured BCG vaccine gets export nod to treat bladder cancer
The Serum Institute of India has been granted permission to export its BCG vaccine to Canada for the treatment of bladder cancer, following a request from the director, Prakash Kumar Singh. BCG as immunotherapy is a live freeze-dried preparation derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin) and is sold in 40mg and 80mg presentations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2023 Category: Pharmaceuticals Source Type: news

Immunotherapy Added to SABR Improves Event-Free Survival in Early NSCLC
(MedPage Today) -- Stereotactic ablative radiotherapy (SABR) combined with immunotherapy (I-SABR) significantly improved event-free survival (EFS) in patients with early-stage or lung parenchymal recurrent node-negative non-small cell lung cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 20, 2023 Category: Hematology Source Type: news

Top-of-the-Art Cytometry to Aid in Lung Cancer Immunotherapy Top-of-the-Art Cytometry to Aid in Lung Cancer Immunotherapy
Learn more about the exciting potential role of cytometry technologies in monitoring immunotherapy treatment responses and predicting adverse events.Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2023 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Penn spinout Verismo Therapeutics raises $17M in second pre-Series A round
Verismo Therapeutics will use the funds to advance its experimental immunotherapies targeting solid tumors and blood cancers. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 18, 2023 Category: Pharmaceuticals Authors: John George Source Type: news

Turning up the Heat on Brain Tumors
Oncolytic viruses can help glioblastoma respond to immunotherapy. (Source: The Scientist)
Source: The Scientist - July 17, 2023 Category: Science Tags: News News & Opinion Source Type: news

Scientists Are Just Beginning to Understand COVID-19 ’ s Effect On the Brain
Early in the COVID-19 pandemic, doctors started to notice something striking. For what was originally described as a respiratory virus, SARS-CoV-2 seemed to have a strong effect on the brain, causing everything from loss of taste and smell and brain fog to, in serious cases, stroke. NYU Langone Health, a New York city research hospital, started collating those anecdotes in hopes of better understanding how the virus affects the brain and nervous system. Years later, the project has morphed from focusing solely on acute symptoms to also tracking the long-term neurologic issues that some people with Long COVID experience, sa...
Source: TIME: Health - July 17, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Immunotherapy Stewardship Could Save Tens of Millions a Year Immunotherapy Stewardship Could Save Tens of Millions a Year
Weight-based dosing, dose rounding, and pharmacy-level vial sharing for immune checkpoint inhibitors could save the Veterans Health Administration more than $70 million annually.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 13, 2023 Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news

Infant Egg Allergy Unaffected by Mom's Early Postnatal Diet
(MedPage Today) -- Infants were no less likely to develop egg allergy if their mother ate eggs in the days after delivery as a means of low-dose oral immunotherapy via breast milk, a randomized clinical trial showed. At 12 months of age, egg allergy... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - July 10, 2023 Category: Allergy & Immunology Source Type: news

Fecal transplants show promise in improving melanoma treatment
In a world-first clinical trial published in the journal Nature Medicine, a multi-centre study from Lawson Health Research Institute, the Centre hospitalier de l'Université de Montréal (CHUM) and the Jewish General Hospital (JGH) has found fecal microbiota transplants (FMT) from healthy donors are safe and show promise in improving response to immunotherapy in patients with advanced melanoma. (Source: World Pharma News)
Source: World Pharma News - July 7, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Episode 4: Immunotoxicity and Metastatic Breast Cancer Episode 4: Immunotoxicity and Metastatic Breast Cancer
Drs Banu Arun and Hope S. Rugo discuss immunotherapy, immunotoxicity, and comorbidities among diverse patient populations in advanced and metastatic breast cancer.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news

A Promising Immunotherapy Against Small Cell Lung Cancer A Promising Immunotherapy Against Small Cell Lung Cancer
This editorial provides commentary on the results from a study investigating the potential of a promising new targeted therapy for small cell lung cancer.Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2023 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news